公司資料

Axon Enterprise, Inc. 股價、新聞與催化劑

股票代碼:
AXON
交易所:
NASDAQ
產業:
Biopharma
所在地:
United States

股票表現

306.98 USD (+2.09%)

收盤價

最後更新: 2026年11月19日

39.5B USD

市值

股價為何變動

最新公司動態「Connected for Safety: How State and Local Agencies Across the Country Are Modernizing Public Safety with Axon」發布後,AXON 於 2026年11月19日 收於 $306.98,較前一交易日上漲 2.09%。該變動發生在與這則公司動態對應的交易時段。

公司概覽

業務概覽

Axon Enterprise is a public safety technology company best known for its TASER devices, body cameras, and cloud software for law-enforcement workflows. Its business is built around hardware plus recurring software and services.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Axon has a growing global public-safety footprint. It is not a biotech or medtech company, but a public-safety technology platform.

商業模式特徵

The company generates revenue through devices, software subscriptions, evidence management, and related services. Investors watch product adoption, recurring software growth, and international expansion.

生技產業定位

Axon is outside biotechnology entirely. If it appears in the database, it belongs in a broader growth-technology bucket rather than the healthcare or biotech stack.

未來催化劑

  • Axon’s catalysts are software adoption, public-safety AI rollout, and continued demand for the body-cam and evidence-management ecosystem. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.

近期新聞

新聞標題由機器翻譯,詳情為英文原文。

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商業成熟度、治療領域或催化劑模式相近的同業公司。